In vitro and in vivo activities of sparfloxacin, other quinolones, and tetracyclines against Chlamydia trachomatis
- 1 January 1992
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 36 (1) , 188-190
- https://doi.org/10.1128/aac.36.1.188
Abstract
Sparfloxacin was more potent than other quinolones (tosufloxacin, lomefloxacin, ciprofloxacin, ofloxacin, fleroxacin, enoxacin, and norfloxacin) and as potent as minocycline and doxycycline in activity against Chlamydia trachomatis in vitro and in vivo. Sparfloxacin was more bactericidal than minocycline against C. trachomatis D/UW-3/Cx.Keywords
This publication has 11 references indexed in Scilit:
- In-vitro activity of azithromycin, erythromycin, ciprofloxacin and norfloxacin against Neisseria gonorrhoeae, Haemophilus ducreyi, and Chlamydia trachomatisJournal of Antimicrobial Chemotherapy, 1990
- Renal handling of fleroxacin in rabbits, dogs, and humansAntimicrobial Agents and Chemotherapy, 1990
- In vitro and in vivo antibacterial activities of AT-4140, a new broad-spectrum quinoloneAntimicrobial Agents and Chemotherapy, 1989
- In vitro activities of T-3262, NY-198, fleroxacin (AM-833; RO 23-6240), and other new quinolone agents against clinically isolated Chlamydia trachomatis strainsAntimicrobial Agents and Chemotherapy, 1988
- Treatment of nongonococcal urethritis with ciprofloxacin.1987
- Ofloxacin: Therapeutic results in chlamydia trachomatis urethritisInfection, 1986
- EVALUATION OF DOXYCYCLINE IN THE TREATMENT OF URETHRITIS AND CERVICITIS CAUSED BY CHLAMYDIA-TRACHOMATIS1986
- Activities of new quinoline derivatives against genital pathogensAntimicrobial Agents and Chemotherapy, 1985
- Pharmacokinetics and tissue penetration of enoxacinAntimicrobial Agents and Chemotherapy, 1984
- Chlamydial InfectionsNew England Journal of Medicine, 1978